Atlas Trials

A Study of TQ05105 in Patients With Chronic Graft Versus Host Disease

Clinical trial NCT04944043 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04944043
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Graft Versus Host Disease
Start date
2021-06-25
Primary completion
2023-06-30
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.